Sign in
CompletedPhase 4

Vonoprazan-Based Triple Therapy in Comparison With Extended Sequential Therapy

Key facts

Who runs it
Fu Jen Catholic University Hospital
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
628 people enrolled
Started
1 Dec 2021
Ended
28 Feb 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Vonoprazan-based triple therapy
  • Extended sequential therapy
Record updated
17 July 2026

Who can take part

Age
20 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Patients with H.pylori infection who was over 20 years old and agree to participate in the trial will be recruited

Who cannot take part

  • Who had received helicobacter pylori eradication before
  • Who are known to be allergic to any drug used in this trial
  • Pregnant women
  • Who are refuse to participate in the trial for any reason

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to compare the efficacy of the current standard first-line anti-helicobacter pylori regimen, extended proton pump inhibitor-based sequential therapy, with that of vonoprazan-based triple therapy, through a randomized controlled trial.

The 2 groups in the trial

  • Vonoprazan-based triple therapy groupTreatment being tested

    Including patients receiving vonoprazan-based triple therapy (vonoprazan 20mg + amoxicillin 1000 mg + clarithromycin 500 mg twice daily for seven days)

    Treatment: Vonoprazan-based triple therapy

  • Extended sequential therapy groupExisting treatment, for comparison

    Including patients receiving extended sequential therapy (lansoprazole 30mg + amoxicillin 1000mg twice daily for 7 days, followed by lansoprazole 30mg + clarithromycin 500mg + metronidazole 500mg twice daily for 7 days)

    Treatment: Extended sequential therapy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Seven-Day Vonoprazan-Based Triple Therapy With High-Dose Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy: A Randomized Controlled Trial in Taiwan
Publications
Record updated
17 July 2026